GoodRx Holdings (GDRX) Cash from Financing Activities (2019 - 2026)
GoodRx Holdings (GDRX) posted Cash from Financing Activities of -$16.3 million for Q1 2026, down 27.11% sequentially from -$12.8 million in Q4 2025, and up 84.46% YoY from -$8.8 million in Q1 2025.
GoodRx Holdings (GDRX) Cash from Financing Activities (2019 - 2026) Analysis & Trends
GoodRx Holdings has reported Cash from Financing Activities for 8 years, with the latest figure at -$16.3 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 84.46% year-over-year to -$16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$145.9 million (up 48.17% YoY) and the FY2025 annual result came in at -$234.5 million, up 30.53% from the prior year.
- Cash from Financing Activities eased to -$16.3 million in Q1 2026 per GDRX's latest filing, from -$12.8 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at -$864000.0 in Q2 2024 and troughed at -$172.1 million in Q3 2024.
- A 5-year average of -$51.5 million and a median of -$16.3 million in 2026 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 97.19% in 2024, then slumped 5794.44% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$4.8 million in 2022, then tumbled by 2524.43% to -$125.6 million in 2023, then jumped by 97.19% to -$3.5 million in 2024, then slumped by 263.37% to -$12.8 million in 2025, then decreased by 27.11% to -$16.3 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$16.3 million, -$12.8 million, and -$65.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | -262.53 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -354.13 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | -137.18 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 3.02 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | -30.48 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 512.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | -7.10 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | -100.55 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | GoodRx Holdings | 1.27 Bn | 972.56 Mn | 179.41 Mn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.02 Mn |
| Jun 30, 2026 | -6.02 Mn |
| Mar 31, 2026 | -16.30 Mn |
| Mar 31, 2026 | -16.30 Mn |
| Dec 31, 2025 | -12.83 Mn |
| Dec 31, 2025 | -12.83 Mn |
| Sep 30, 2025 | -65.81 Mn |
| Sep 30, 2025 | -65.81 Mn |
| Jun 30, 2025 | -50.93 Mn |
| Jun 30, 2025 | -50.93 Mn |
| Mar 31, 2025 | -104.90 Mn |
| Mar 31, 2025 | -104.90 Mn |
| Dec 31, 2024 | -3.53 Mn |
| Dec 31, 2024 | -3.53 Mn |
| Sep 30, 2024 | -172.13 Mn |
| Sep 30, 2024 | -172.13 Mn |
| Jun 30, 2024 | -864,000.00 |
| Jun 30, 2024 | -864,000.00 |
| Mar 31, 2024 | -160.97 Mn |
| Mar 31, 2024 | -160.97 Mn |